Clinical Trial Update: Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating memory reconsolidation blockers as a potential treatment for Post-traumatic Stress Disorder; the study is completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Snippet

Sponsor: Roger K. Pitman, MD | Conditions: Post-traumatic Stress Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-06-29